Cytochrome P450 2C19 genotype -based second line therapy with amoxicillin and lansoprazole after failure of initial helicobacter pylori eradication therapy
Asano, M.; Taniwaki, H.; Tsuji, D.; Sato, Y.; Shimizu, T.
Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 12): 450-453
2005
ISSN/ISBN: 0047-1852 PMID: 16416832 Document Number: 586273
Document emailed within 1 workday
Related Documents
Kullavanijaya, P.; Gonlachanvit, S.; Mahachai, V.; Kladchareon, N. 2000: Eradication of Helicobacter pylori with lansoprazole based triple therapy in peptic ulcer disease Journal of the Medical Association of Thailand 83(3): 230-235Satoh, K. 2009: Second-line therapy for patients with Helicobacter pylori eradication failure Nihon Rinsho. Japanese Journal of Clinical Medicine 67(12): 2297-2302
Adamek, R.J.; Wegener, M.; Birkholz, S.; Opferkuch, W.; Rühl, G.H.; Ricken, D. 1992: Modified combined omeprazole/amoxicillin therapy for Helicobacter pylori eradication: a pilot study Leber Magen Darm 22(6): 222-224
Sekine, H.; Ohara, S.; Iijima, K.; Kato, K. 1999: Recurrence rate of H. pylori after successful eradication and second eradication therapy after initial failure of treatment Nihon Rinsho. Japanese Journal of Clinical Medicine 57(1): 116-120
Aminian, K.; Farsad, F.; Ghanbari, A.; Fakhreih, S.; Hasheminasab, S.M. 2010: A randomized trial comparing four Helicobacter pylori eradication regimens: standard triple therapy, ciprofloxacin based triple therapy, quadruple and sequential therapy Tropical Gastroenterology: Official Journal of the Digestive Diseases Foundation 31(4): 303-307
Ren, Q.; Ma, B.; Yang, K.; Yan, X. 2010: Lafutidine-based triple therapy for Helicobacter pylori eradication Hepato-Gastroenterology 57: 102-103
al-Assi, M.T.; Cole, R.A.; Karttunen, T.J.; el-Zimaity, H.; Genta, R.M.; Graham, D.Y. 1995: Treatment of Helicobacter pylori infection with omeprazole-amoxicillin combination therapy versus ranitidine/sodium bicarbonate-amoxicillin American Journal of Gastroenterology 90(9): 1411-1414
Lou, J-gan.; Chen, J.; Huang, X-lei.; Zhao, Z-yan. 2007: Changes in the intestinal microflora of children with Helicobacter pylori infection and after Helicobacter pylori eradication therapy Chinese Medical Journal 120(10): 929-931
Gupta, V.K.; Dhar, A.; Srinivasan, S.; Rattan, A.; Sharma, M.P. 1997: Eradication of H. pylori in a developing country: comparison of lansoprazole versus omeprazole with norfloxacin, in a dual-therapy study American Journal of Gastroenterology 92(7): 1140-1142
Labenz, J.; Gyenes, E.; Rühl, G.H.; Börsch, G. 1992: Two weeks treatment with amoxicillin/omeprazole for eradication of Helicobacter pylori Zeitschrift für Gastroenterologie 30(11): 776-778
Furuta, T.; Sugimoto, M.; Kodaira, C.; Nishino, M.; Yamade, M.; Uotani, T.; Ikuma, M.; Shirai, N. 2010: The dual therapy with 4 times daily dosing of rabeprazole and amoxicillin as the 3rd rescue regimen for eradication of H. pylori Hepato-Gastroenterology 57: 102-103
Zala, G.; Wirth, H.P.; Bauer, S.; Wüst, J.; Flury, R.; Meyenberger, C.; Ammann, R. 1994: Eradication of metronidazole-resistant Helicobacter pylori: is omeprazole/amoxicillin a therapeutic alternative? Schweizerische Medizinische Wochenschrift 124(31-32): 1385-1390
Aoyama, N.; Shirasaka, D.; Miki, I. 2003: Tailor-made medicine in Helicobacter pylori eradication therapy Nihon Rinsho. Japanese Journal of Clinical Medicine 61(1): 129-136
Nakamura, T.; Terano, A. 2002: Eradication therapy of Helicobacter pylori for elderly patients in Japan Nihon Rinsho. Japanese Journal of Clinical Medicine 60(8): 1566-1572
Satoh, K.; Sugano, K. 2009: Helicobacter pylori eradication therapy for peptic ulcer disease Nihon Rinsho. Japanese Journal of Clinical Medicine 67(12): 2322-2326
Shimizu, N.; Kubota, K.; Kaminishi, M. 2005: Eradication therapy for the remnant stomach infected with Helicobacter pylori Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 11): 478-481
Eremina, E.Iu.; Bondarenko, V.M.; Zvereva, S.I.; Nikitina, O.I.; Shaposhnikova, L.I. 2008: Dysbiotic manifestations during eradication therapy of Helicobacter pylori and their corrections Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2008(3): 62-66
Parzecka, M.; Szaflarska-Popławska, A.; Mierzwa, G.; Gorzkiewicz, M.; Łuczak, S.; Grzybowski, T. 2009: Genetic type of Helicobacter pylori and the efficacy of eradication therapy Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 26(152): 105-109
Blum, A.L.; Kreiss, C.; Armstrong, D. 1995: Functional dyspepsia: approaches to Helicobacter pylori eradication therapy Leber Magen Darm 25(3): 112-116; 119-120
Bock, H.; Mares, A. 1997: Current status of Helicobacter pylori eradication therapy. Significance of roxithromycin Fortschritte der Medizin 115(27): 54-55